Literature DB >> 19411385

Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome.

David E Kemp, Faramarz Ismail-Beigi, Joseph R Calabrese.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19411385      PMCID： PMC3904749          DOI： 10.1176/appi.ajp.2008.08081195

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  3 in total

1.  Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities.

Authors:  Roger S McIntyre; Joanna K Soczynska; Gary F Lewis; Glenda M MacQueen; Jakub Z Konarski; Sidney H Kennedy
Journal:  Expert Opin Pharmacother       Date:  2006-07       Impact factor: 3.889

2.  Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study.

Authors:  Hannu Koponen; Jari Jokelainen; Sirkka Keinänen-Kiukaanniemi; Esko Kumpusalo; Mauno Vanhala
Journal:  J Clin Psychiatry       Date:  2008-02       Impact factor: 4.384

3.  Depressive symptoms and metabolic syndrome: is inflammation the underlying link?

Authors:  Lucile Capuron; Shaoyong Su; Andrew H Miller; J Douglas Bremner; Jack Goldberg; Gerald J Vogt; Carisa Maisano; Linda Jones; Nancy V Murrah; Viola Vaccarino
Journal:  Biol Psychiatry       Date:  2008-07-02       Impact factor: 13.382
  3 in total
  21 in total

1.  Pioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitus.

Authors:  Yaozhi Hu; Haiyan Xing; Xiaomeng Dong; Wenxian Lu; Xinxing Xiao; Lilin Gao; Minghu Cui; Jinbo Chen
Journal:  Exp Ther Med       Date:  2015-06-24       Impact factor: 2.447

2.  PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.

Authors:  David E Kemp; Martha Schinagle; Keming Gao; Carla Conroy; Stephen J Ganocy; Faramarz Ismail-Beigi; Joseph R Calabrese
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

Review 3.  Targeting the immune system in the treatment of bipolar disorder.

Authors:  Joshua D Rosenblat
Journal:  Psychopharmacology (Berl)       Date:  2019-02-13       Impact factor: 4.530

Review 4.  Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre-clinical systematic review.

Authors:  Amanda T White; Anne N Murphy
Journal:  J Neurochem       Date:  2010-10-07       Impact factor: 5.372

5.  Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

Authors:  Khatereh Sepanjnia; Amirhossein Modabbernia; Mandana Ashrafi; Mohammad-Jafar Modabbernia; Shahin Akhondzadeh
Journal:  Neuropsychopharmacology       Date:  2012-05-02       Impact factor: 7.853

6.  NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice.

Authors:  Mohammad Salehi-Sadaghiani; Mehrak Javadi-Paydar; Mohammad Hadi Gharedaghi; Ali Zandieh; Pouria Heydarpour; Yashar Yousefzadeh-Fard; Ahmad Reza Dehpour
Journal:  Psychopharmacology (Berl)       Date:  2012-05-01       Impact factor: 4.530

7.  Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.

Authors:  David E Kemp; Faramarz Ismail-Beigi; Stephen J Ganocy; Carla Conroy; Keming Gao; Sarah Obral; Elizabeth Fein; Robert L Findling; Joseph R Calabrese
Journal:  J Affect Disord       Date:  2011-07-22       Impact factor: 4.839

8.  Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor.

Authors:  Lizath M Aguiniga; Wenbin Yang; Ryan E Yaggie; Anthony J Schaeffer; David J Klumpp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-04-24       Impact factor: 3.619

9.  The risk of developing type 2 diabetes mellitus associated with psychotropic drug use in children and adolescents: a retrospective cohort analysis.

Authors:  Jeanette M Jerrell; Avnish Tripathi; Ali A Rizvi; Roger S McIntyre
Journal:  Prim Care Companion CNS Disord       Date:  2012-01-12

10.  Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome.

Authors:  David E Kemp; Keming Gao; Philip K Chan; Stephen J Ganocy; Robert L Findling; Joseph R Calabrese
Journal:  Bipolar Disord       Date:  2010-06       Impact factor: 6.744
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.